Found: 12
Select item for more details and to access through your institution.
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 821, doi. 10.1007/s10637-019-00824-1
- By:
- Publication type:
- Article
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 442, doi. 10.1007/s10637-017-0519-z
- By:
- Publication type:
- Article
Thymidylate Synthase Genotype-Directed Chemotherapy for Patients with Gastric and Gastroesophageal Junction Cancers.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107424
- By:
- Publication type:
- Article
Treatment of Early-Stage Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 182
- By:
- Publication type:
- Article
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2144170, doi. 10.1001/jamanetworkopen.2021.44170
- By:
- Publication type:
- Article
Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 572, doi. 10.1002/cam4.208
- By:
- Publication type:
- Article
Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1104, doi. 10.1002/onco.13758
- By:
- Publication type:
- Article
Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. 669, doi. 10.1634/theoncologist.2019-0637
- By:
- Publication type:
- Article
Pancreatic Cancer in Young Adults: Can Innovative Approaches Lead to Better Outcomes?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Pancreas Cancer on the Rise: Are We Up to the Challenge?
- Published in:
- 2013
- By:
- Publication type:
- Editorial